Indian and South African interests have diverged; India is not in desperate need of vaccines anymore and doesn’t want to rock the boat

Health advocates are asking Washington to use laws that allow patent override on drugs developed with public funds

Tough new conditions emerge in the compromise deal to ease WTO intellectual property barriers related to production of COVID-19 medical tools

By using IP rights as a tool of war, Russia is taking a leaf out of the US' book to seize copyright and patents owned by 'unfriendly' countries

New Delhi has not backed its WTO proposal to suspend intellectual property rights on COVID-19 pharma products with robust action

Punching way above its weight, the tiny nation has developed five vaccines, and offers hope of vaccine equity across the world

The application for securing GI tag for Banarasi paan appears to be misplaced, and could potentially lead to controversies

IFPMA, the biopharma trade body, has made its claim clear: COVID-19 vaccine management should be left to a handful of companies, and all blame lies...

A greed-driven vaccine market, backed by rich countries’ frivolous rush for booster doses, has deprived poor countries of their share of jabs

Opposition to the new patent claims on the Johnson & Johnson drug is a test of how well the rules against evergreening are working

There is unease over the crusader of natural farming, Subhash Palekar, for renaming the technique after himself

As prices of the life-saving drugs skyrocket, people from diverse fields are getting together to fight Big Pharma